• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of the fluoropyrimidines: implications for their clinical use.

作者信息

Myers C E, Diasio R, Eliot H M, Chabner B A

出版信息

Cancer Treat Rev. 1976 Sep;3(3):175-83. doi: 10.1016/s0305-7372(76)80021-7.

DOI:10.1016/s0305-7372(76)80021-7
PMID:963687
Abstract
摘要

相似文献

1
Pharmacokinetics of the fluoropyrimidines: implications for their clinical use.氟嘧啶类药物的药代动力学：对其临床应用的启示。
Cancer Treat Rev. 1976 Sep;3(3):175-83. doi: 10.1016/s0305-7372(76)80021-7.
2
5-fluorouracil and dihydropyrimidine dehydrogenase.5-氟尿嘧啶与二氢嘧啶脱氢酶
Int J Clin Oncol. 2003 Jun;8(3):127-31. doi: 10.1007/s10147-003-0319-7.
3
[Indications for fluorouracil in dermatology].
Med Cutan Ibero Lat Am. 1974(2):107-14.
4
[Mode of action of fluoropyrimidines, in relation to their clinical application].
Gan To Kagaku Ryoho. 1984 Nov;11(11):2301-6.
5
Clinical implications of dihydropyrimidine dehydrogenase inhibition.二氢嘧啶脱氢酶抑制的临床意义。
Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):17-21.
6
From 5 fluorouracil to the new oral fluoropyrimidines: a brief overview of four decades of clinical investigations.
Isr Med Assoc J. 2001 Apr;3(4):278-81.
7
[5-fluorouracil and dihydropyrimidine dehydrogenase].[5-氟尿嘧啶与二氢嘧啶脱氢酶]
Gan To Kagaku Ryoho. 2001 Apr;28(4):433-9.
8
[Factors of the therapeutic effectiveness of 5-fluorouracil].[5-氟尿嘧啶治疗效果的影响因素]
Vopr Onkol. 1996;42(2):31-6.
9
Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.
Adv Pharmacol Chemother. 1980;17:289-321. doi: 10.1016/s1054-3589(08)60013-7.
10
Fluorouracil.氟尿嘧啶
Clin J Oncol Nurs. 1999 Oct;3(4):191-2.

引用本文的文献

1
Evaluating the Antibacterial and Antivirulence Activities of Floxuridine against .评估氟尿苷对……的抗菌和抗毒力活性
Int J Mol Sci. 2023 Sep 18;24(18):14211. doi: 10.3390/ijms241814211.
2
Difference in Neutropenia due to Administration Schedule of TAS-102.TAS-102给药方案导致的中性粒细胞减少症差异。
Case Rep Oncol. 2017 Mar 2;10(1):226-229. doi: 10.1159/000460242. eCollection 2017 Jan-Apr.
3
Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.2'-脱氧肌苷作为5-氟尿嘧啶调节剂的隐形脂质体制剂的研发：体外和体内研究
Pharm Res. 2005 Dec;22(12):2051-7. doi: 10.1007/s11095-005-8355-9. Epub 2005 Oct 21.
4
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.一项针对结直肠癌患者的高剂量5-氟尿嘧啶和亚叶酸24小时持续输注及低剂量丙氨酸-磷酸核糖基转移酶抑制剂的II期试点研究：一项西南肿瘤协作组研究
Invest New Drugs. 2004 Nov;22(4):467-73. doi: 10.1023/B:DRUG.0000036689.28596.c6.
5
First-line treatment strategies to improve survival in patients with advanced colorectal cancer.
Drugs. 2004;64(1):27-44. doi: 10.2165/00003495-200464010-00003.
6
Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).呋喃氟尿嘧啶（R,S-1-(四氢-2-呋喃基)-5-氟尿嘧啶）的立体选择性代谢
Cancer Chemother Pharmacol. 1981;7(1):55-9. doi: 10.1007/BF00258214.
7
Clinical pharmacokinetics of commonly used anticancer drugs.常用抗癌药物的临床药代动力学
Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002.
8
Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.
Cancer Chemother Pharmacol. 1986;16(1):43-9. doi: 10.1007/BF00255284.
9
Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig.肝动脉内输注5-氟尿嘧啶（5-FU）后的心肺血流动力学和药代动力学。猪的实验研究。
Cancer Chemother Pharmacol. 1988;22(3):251-5. doi: 10.1007/BF00273420.
10
Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.肿瘤学中的治疗药物监测。抗肿瘤治疗中的问题与潜力。
Clin Pharmacokinet. 1987 Oct;13(4):205-27. doi: 10.2165/00003088-198713040-00001.